EU regulator advises AstraZeneca's COVID drug be cleared

Norge Nyheter Nyheter

EU regulator advises AstraZeneca's COVID drug be cleared
Norge Siste Nytt,Norge Overskrifter
  • 📰 ABC
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 51%

The European Union's drug regulator said it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus.

FILE - Jose Lazaro, a medical assistant at a University of Washington Medicine clinic, prepares a two-shot dose of AstraZeneca's Evusheld, the first set of antibodies grown in a lab to prevent COVID-19, on Jan. 20, 2022, in Seattle. The European Medicines Agency said it is recommending that an antibody drug developed by AstraZeneca be authorized to help people avoid getting sick with the coronavirus.

“When the antibodies in Evusheld attach to the spike protein, the virus cannot enter the cells to multiply and is unable to cause COVID-19 infection,” the EMA said. The agency said it had assessed data on the drug from more than 5,000 people and found Evusheld reduced the risk of infection by 77%, with protection estimated to last at least six months.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

ABC /  🏆 471. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

EXPLAINER: What to know about COVID vaccines for little kidsEXPLAINER: What to know about COVID vaccines for little kidsModerna says it will ask regulators to authorize its COVID-19 vaccine for children under 6 but several hurdles need to be cleared before the shots could become available.
Les mer »

Moderna says its low-dose COVID shots work for kids under 6Moderna says its low-dose COVID shots work for kids under 6Moderna’s COVID-19 vaccine works in babies, toddlers and preschoolers the company announced Wednesday -- and if regulators agree it could mean a chance to finally start vaccinating the littlest kids by summer.
Les mer »

Low-dose COVID shots effective for babies and toddlers, Moderna saysLow-dose COVID shots effective for babies and toddlers, Moderna saysModerna’s COVID-19 vaccine works in babies, toddlers and preschoolers the company announced Wednesday -- and if regulators agree it could mean a chance to finally start vaccinating the littlest kids by summer.
Les mer »

Moderna says its low-dose COVID shots work for kids under 6; will seek federal approvalModerna says its low-dose COVID shots work for kids under 6; will seek federal approvalModerna's COVID-19 vaccine works in babies, toddlers and preschoolers the company announced Wednesday -- and if regulators agree it could mean a chance to finally start vaccinating the littlest kids by summer.
Les mer »

Moderna says its low-dose COVID shots work for kids under 6Moderna says its low-dose COVID shots work for kids under 6Moderna’s COVID-19 vaccine works in babies, toddlers and preschoolers the company announced Wednesday — and if regulators agree it could mean a chance to...
Les mer »



Render Time: 2025-03-10 12:46:04